News & Updates
Filter by Specialty:
Neurologic disability predicts severe ED in men infected with HTLV-1
Patients with human T-lymphotropic virus 1 (HTLV-1) infection may develop erectile dysfunction (ED), and time to progression to its severe form is significantly associated with the degree of neurologic compromise at baseline, reveals a study.
Neurologic disability predicts severe ED in men infected with HTLV-1
21 Mar 2023
CBT, mindfulness help improve sexual outcomes in prostate cancer
Mindfulness and cognitive behavioural therapy (CBT) appear beneficial for prostate cancer survivors and their partners who are dealing with sexual dysfunction, a study has shown.
CBT, mindfulness help improve sexual outcomes in prostate cancer
21 Mar 2023
HCC risk in CHB patients persists 12 years after HBsAg loss
Patients with chronic hepatitis B (CHB) still have a non-negligible risk of hepatocellular carcinoma (HCC) 12 years after achieving hepatitis B surface antigen (HBsAg) seroclearance, especially if cirrhosis is present, a large territory-wide real-world study in Hong Kong has shown.
HCC risk in CHB patients persists 12 years after HBsAg loss
21 Mar 2023
PCSK9 inhibition tied to decreased psoriasis risk
Inhibition of the proprotein convertase subtilisin/kexin type 9 (PCSK9) pathway appears to be causally associated with a lower risk of psoriasis, regardless of the concentration levels of circulating low-density lipoprotein (LDL), according a two-sample Mendelian randomization study.
PCSK9 inhibition tied to decreased psoriasis risk
20 Mar 2023
Telbivudine use during pregnancy safe, effective in HBsAG-positive mothers
Use of telbivudine (LdT) during the second trimester of pregnancy helps prevent mother-to-child transmission of hepatitis B virus, reveals a study. In addition, treatment with LdT during pregnancy is safe in the long term for both mothers and infants.
